Cargando…

Novel insights into the antibacterial activities of cannabinoid biosynthetic intermediate, olivetolic acid, and its alkyl-chain derivatives

Investigations of antibacterial activities revealed that the incorporation of longer alkyl chains to the C-6 position in resorcylic acid conferred antibacterial properties against Staphylococcus aureus and Bacillus subtilis. The resultant olivetolic acid (OA) derivatives with n-undecyl and n-tridecy...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yuan-E, Kodama, Takeshi, Morita, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792157/
https://www.ncbi.nlm.nih.gov/pubmed/36572832
http://dx.doi.org/10.1007/s11418-022-01672-9
_version_ 1784859573405876224
author Lee, Yuan-E
Kodama, Takeshi
Morita, Hiroyuki
author_facet Lee, Yuan-E
Kodama, Takeshi
Morita, Hiroyuki
author_sort Lee, Yuan-E
collection PubMed
description Investigations of antibacterial activities revealed that the incorporation of longer alkyl chains to the C-6 position in resorcylic acid conferred antibacterial properties against Staphylococcus aureus and Bacillus subtilis. The resultant olivetolic acid (OA) derivatives with n-undecyl and n-tridecyl side-chains, even those lacking the hydrophobic geranyl moiety from their C-3 positions, exhibited strong antibacterial activities against B. subtilis at a MIC value of 2.5 μM. Furthermore, the study demonstrated that the n-heptyl alkyl-chain modification at C-6 of cannabigerolic acid (CBGA) effectively enhanced the activity against B. subtilis, demonstrating the importance of the alkyl side-chain in modulating the bioactivity. Overall, the findings in this study provided insight into further evaluations of the antibacterial activities, as well as other various biological activities of OA and CBGA derivatives, especially with optimized hydrophobicities at both the alkyl and prenyl side-chain positions of the core skeleton for the discovery of novel drug seeds. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11418-022-01672-9.
format Online
Article
Text
id pubmed-9792157
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Nature Singapore
record_format MEDLINE/PubMed
spelling pubmed-97921572022-12-27 Novel insights into the antibacterial activities of cannabinoid biosynthetic intermediate, olivetolic acid, and its alkyl-chain derivatives Lee, Yuan-E Kodama, Takeshi Morita, Hiroyuki J Nat Med Original Paper Investigations of antibacterial activities revealed that the incorporation of longer alkyl chains to the C-6 position in resorcylic acid conferred antibacterial properties against Staphylococcus aureus and Bacillus subtilis. The resultant olivetolic acid (OA) derivatives with n-undecyl and n-tridecyl side-chains, even those lacking the hydrophobic geranyl moiety from their C-3 positions, exhibited strong antibacterial activities against B. subtilis at a MIC value of 2.5 μM. Furthermore, the study demonstrated that the n-heptyl alkyl-chain modification at C-6 of cannabigerolic acid (CBGA) effectively enhanced the activity against B. subtilis, demonstrating the importance of the alkyl side-chain in modulating the bioactivity. Overall, the findings in this study provided insight into further evaluations of the antibacterial activities, as well as other various biological activities of OA and CBGA derivatives, especially with optimized hydrophobicities at both the alkyl and prenyl side-chain positions of the core skeleton for the discovery of novel drug seeds. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11418-022-01672-9. Springer Nature Singapore 2022-12-26 2023 /pmc/articles/PMC9792157/ /pubmed/36572832 http://dx.doi.org/10.1007/s11418-022-01672-9 Text en © The Author(s) under exclusive licence to The Japanese Society of Pharmacognosy 2022, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Paper
Lee, Yuan-E
Kodama, Takeshi
Morita, Hiroyuki
Novel insights into the antibacterial activities of cannabinoid biosynthetic intermediate, olivetolic acid, and its alkyl-chain derivatives
title Novel insights into the antibacterial activities of cannabinoid biosynthetic intermediate, olivetolic acid, and its alkyl-chain derivatives
title_full Novel insights into the antibacterial activities of cannabinoid biosynthetic intermediate, olivetolic acid, and its alkyl-chain derivatives
title_fullStr Novel insights into the antibacterial activities of cannabinoid biosynthetic intermediate, olivetolic acid, and its alkyl-chain derivatives
title_full_unstemmed Novel insights into the antibacterial activities of cannabinoid biosynthetic intermediate, olivetolic acid, and its alkyl-chain derivatives
title_short Novel insights into the antibacterial activities of cannabinoid biosynthetic intermediate, olivetolic acid, and its alkyl-chain derivatives
title_sort novel insights into the antibacterial activities of cannabinoid biosynthetic intermediate, olivetolic acid, and its alkyl-chain derivatives
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792157/
https://www.ncbi.nlm.nih.gov/pubmed/36572832
http://dx.doi.org/10.1007/s11418-022-01672-9
work_keys_str_mv AT leeyuane novelinsightsintotheantibacterialactivitiesofcannabinoidbiosyntheticintermediateolivetolicacidanditsalkylchainderivatives
AT kodamatakeshi novelinsightsintotheantibacterialactivitiesofcannabinoidbiosyntheticintermediateolivetolicacidanditsalkylchainderivatives
AT moritahiroyuki novelinsightsintotheantibacterialactivitiesofcannabinoidbiosyntheticintermediateolivetolicacidanditsalkylchainderivatives